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 ARTICLE
The origin of heterogeneous nanoparticle uptake
by cells
Paul Rees1,2,4, John W. Wills3,4, M. Rowan Brown1, Claire M. Barnes1 & Huw D. Summers1
Understanding nanoparticle uptake by biological cells is fundamentally important to wide-
ranging ﬁelds from nanotoxicology to drug delivery. It is now accepted that the arrival of
nanoparticles at the cell is an extremely complicated process, shaped by many factors
including unique nanoparticle physico-chemical characteristics, protein-particle interactions
and subsequent agglomeration, diffusion and sedimentation. Sequentially, the nanoparticle
internalisation process itself is also complex, and controlled by multiple aspects of a cell’s
state. Despite this multitude of factors, here we demonstrate that the statistical distribution
of the nanoparticle dose per endosome is independent of the initial administered dose and
exposure duration. Rather, it is the number of nanoparticle containing endosomes that are
dependent on these initial dosing conditions. These observations explain the heterogeneity of
nanoparticle delivery at the cellular level and allow the derivation of simple, yet powerful
probabilistic distributions that accurately predict the nanoparticle dose delivered to individual
cells across a population.
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1 Centre for Nanohealth, Swansea University College of Engineering, Fabian Way, Crymlyn Burrows, Swansea SA1 8EN, UK. 2 Broad Institute of MIT and
Harvard, 415 Main Street, Cambridge, MA 02142, USA. 3 Biominerals Research, Cambridge University Department of Veterinary Medicine, School of
Biological Sciences, Madingley Road, Cambridge CB3 0ES, UK. 4These authors contributed equally: Paul Rees, John W. Wills. Correspondence and requests
for materials should be addressed to P.R. (email: p.rees@swansea.ac.uk) or to J.W.W. (email: jw2020@cam.ac.uk)
NATURE COMMUNICATIONS |         (2019) 10:2341 | https://doi.org/10.1038/s41467-019-10112-4 |www.nature.com/naturecommunications 1
12
34
56
78
9
0
()
:,;
There is a recognised demand for quantiﬁable and robustmetrics for assessing the uptake of nanoparticles by cellsdriven by ﬁelds of research from nanosafety assessment to
drug delivery1–3. In a typical in vitro study, a speciﬁc dose of
nanoparticles is administered into a biological medium contain-
ing cells. The subsequent delivery of the nanoparticles to the
cells is known to be a highly complicated process involving dif-
fusion and/or sedimentation4 of the nanoparticles in the liquid
medium4,5. Nanoparticle agglomeration is further dependent on
the content of the media6 and the functional coating on the
particles, and can also dramatically alter cellular uptake dynam-
ics6–8. Upon arrival at the cell surface, there are multiple pro-
cesses by which nanoparticles can be internalised by the cell, e.g.,
phagocytosis, endocytosis, direct trans-membrane transport, etc.,
and once internalised within the cell, there are many locations to
which nanoparticles are routed7. This multitude of factors has
led to much debate around the appropriate physico-chemical
parameters to consider when quantifying nanoparticle cellular
delivery, e.g., size, shape, surface area and charge, etc.8–10.
Despite the vast number of factors that affect the cellular uptake of
nanoparticles, we have previously shown that because the number of
particles internalised by cells is random, the dose acquired by each
cell can be described by well-deﬁned probability distribution func-
tions11. Given the number of nanoparticles in the medium for a
typical exposure, and the size of particles relative to the cell, it is
appropriate to assume that the delivery to the cell surface corre-
sponds to a Poisson arrival process, i.e., a series of independent
random events in time. However, measured distributions of
nanoparticle-loaded vesicles (NLVs) deviate from the simple Poisson
case and exhibit over-dispersion11. This indicates the presence of
additional processes, beyond just particle arrival at the membrane,
which play a role in determining particle uptake. It also raises the
question of whether the prediction of the cellularly internalised dose
based on mechanism-related models is possible—given the com-
plexities suggested by the over-dispersed characteristics.
To get to the root of this heterogeneity, here we use high-
throughput microscopy and image analysis to study nanoparticle
delivery for a range of dosing conditions and cell lines. This
allows us to measure the number of nanoparticles encapsulated in
individual vesicles (in excess of 105 per exposure condition)
across tens of thousands of cells, yielding highly accurate prob-
ability distributions of acquired dose at the vesicle and whole-cell
level. Our approach reveals the fundamental processes that
inevitably lead to the random nature of nanoparticle dosing, and
provides a simple predictive equation that allows researchers to
determine the cell-to-cell variation in nanoparticle uptake that
can be expected for their particular cell line, nanoparticle and
dose conditions.
Results
High-throughput microscopy strategy and NLV over-
dispersity. In this paper, we measure the uptake of commer-
cially available, ~8 nm Qtracker 705 quantum dot nanoparticles
(physico-chemical characteristics described in Supplementary
Table 1) by endocytosis for A549 (adenocarcinomic human
alveolar epithelial cells) and BEAS-2B (normal human bronchial
epithelial cells) exposed to 0.5, 2, 4 or 5 nanomolar administered
doses for durations of 0.5, 1 or 2 h. For each experiment, we used
CellProﬁler12 to segment the nucleus, cell membrane and any
NLV within each cell object (Fig. 1a,b and Supplementary Figs. 1–
4). The CellProﬁler pipeline (provided alongside sample data,
Supplementary Note 1 and Supplementary Data 1) enabled pre-
cise measurement of each cell’s area (Fig. 1c), the number of
NLVs per cell (Fig. 1d), as well as the ﬂuorescence intensity of
every NLV across 105 ﬁelds-of-view collected per experiment. In
previous work correlating ﬂuorescence measurements against
counts of nanoparticle numbers per vesicle using electron
microscopy, we veriﬁed Qtracker ﬂuorescence as an excellent
surrogate measure of the total number of nanoparticles per
vesicle13. Use of a ﬂuorescent nuclear marker further allowed us
to measure the DNA content of each cell, and to relate this to the
functional state of the cell in terms of cell cycle position (Fig. 1e).
The large number of cells (>10,000) and endosomes (~0–40 per
cell) analysed per experiment provided statistically relevant
numbers enabling us to generate accurate probability density
functions to describe cell area, NLVs per cell and nanoparticle
loading per vesicle across each cell population (exact cell/NLV n
sizes for all 12 exposures are provided, Supplementary Figs. 3, 4).
The probability distribution describing the number of NLVs per
cell for each combination of nanoparticle dose and exposure time
was over-dispersed, i.e., the variance is greater than the mean,
conﬁrming previous studies11,13 (Fig. 1d).
Dose per cell versus dose per endosome. Considering the results,
the mean number of NLVs per cell increases linearly with
increasing administered dose and duration of exposure as
expected (Fig. 2a–d). However, somewhat surprisingly, the
ﬂuorescence intensity distributions of the NLVs (equating to the
number of nanoparticles encapsulated within the vesicle) are
independent of these experimental conditions (Fig. 2e–g, further
results shown Supplementary Fig. 5). This indicates that the
distribution of the nanoparticle dose encapsulated in each vesicle
is highly similar for both cell lines and is ﬁxed, being independent
of the administered dose and exposure duration over a 16-fold
variation in the dose-time product. Instead, the higher delivered
cellular dose that follows increasing exposure manifests from an
increase in the number of NLVs, and not from the loading of
greater numbers of nanoparticles into individual endosomes. This
implies that the endosomal loading is primarily determined by
endocytosis dynamics rather than the particle arrival kinetics
under these dosing conditions.
A probabilistic model to describe nanoparticle uptake. Given
these observations, we can derive a complete analytical model
that describes the statistical distribution of NLVs (and therefore
also the distribution of the nanoparticle dose captured by each
cell) for a given nanoparticle administered dose and exposure
duration. The rate of formation of endosomes by a cell can be
described as a spatiotemporal Poisson process, which is depen-
dent on the area and turnover rate of the cell membrane14. The
distribution of cell area across a population can be approximated
by a gamma function (Fig. 1c and Supplementary Figs. 6, 7),
which means the endosome formation rate per cell is then given
by a negative binominal distribution (see Methods for derivation).
We note that this assumes that the cell area is constant during
nanoparticle exposure, which might become less valid over long
exposure times or for high doses of nanoparticles where toxicity
perturbations can lead to cell shrinkage15. The generation of an
NLV depends on the arrival of at least one nanoparticle/
agglomerate at the site of a nascent endosome. The particle
interaction also has to take place within the lifetime of endosome
formation at the membrane, which is typically in the range of
40–400 s16. The resulting vesicular dose is therefore dependent
upon the spatial and temporal dynamics of both forming endo-
somes and particle-binding events (Fig. 3a). This interplay of
processes determines whether particles arrive into the same
endosome and thus increase the intra-vesicle dose, or bind to new
vesicles to increase the NLV count. In practice, for typical
nanomolar dose ranges, the endosome formation time is short
compared to the inter-event time for particle arrival, and so the
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overwhelming probability is that particles bind to newly forming
endosomes. In a typical cell, ≫102 endosomes form within a 1-h
period14 (Supplementary Fig. 8), and so the observation of ~1–40
NLVs per cell (Fig. 3b) conﬁrms this hypothesis.
The observation that the arrival of a nanoparticle/agglomerate
into a forming endosome is slow enough that the endosome
captures at most only one event allows us to thin the coupled
endosome formation–particle capture Poisson processes17 and
arrive at a negative binomial probability distribution describing
the number of NLVs per cell, N due to exposure of cell population
to nanoparticle concentration C for a time, t;:
p N; r; pð Þ ¼ Γ r þ Nð Þ
N!Γ rð Þ p
N 1 pð Þr; ð1Þ
where r= α, p= βλCt/(1+ βλCt) and α and β describe the
gamma distributions of cell area (see Methods for derivation and
assumptions). The shape factor α and scale factor β are
determined by ﬁtting the measured cell area distributions
(Supplementary Figs. 6, 7), λ is the formation rate of NLVs in
terms of concentration per unit time, per unit area. We are
therefore able to predict the number of NLVs using a probabilistic
model with just one scaling parameter, λ, which remains constant
across all exposure doses and times.
The mean number of NLVs per cell described by the negative
binomial distribution in Eq. 1 can be derived to be νnb ¼
λ ´ αβ ´Ct (see Methods for derivation), therefore the least
squares ﬁt to the mean NLV versus dose–time product (Fig. 2c, d)
can be used to derive a value of λ of 0.00107 nM−1 h−1 m−2 for
BEAS-2B and 0.00135 nM−1 h−1 m−2 for A549. Using these
values, there is an excellent agreement between the experimental
and theoretical distributions for all three doses shown and for an
increased exposure time of 2 h (Fig. 3b and Supplementary
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Fig. 1 Image-based analysis of nanoparticle delivery to adherent cells. a A typical ﬁeld-of-view (taken from >100 per experiment) imaged by laser scanning
confocal microscopy of lung adenocarcinoma A549 cells exposed to a 2.0-nM dose of Qtracker® 705 quantum dot nanoparticles for 1 h. Cell identiﬁcation
numbers alongside nuclear and cell membrane segmentation masks achieved by image analysis (see Methods) are shown as blue and red lines,
respectively. b For each cell (segmentation outlines shown), individual nanoparticle-loaded vesicles (NLVs) were also segmented (red outlines). c–e In this
way, image analysis allowed nuclear, cell and NLV features (e.g., size, shape and ﬂuorescence intensity) to be measured for ~104 cells and ~105 NLVs for
each exposure condition (i.e., dose–time combination). This allowed factors such as area (c), number of NLVs (d) and the DNA content (e) of each
cell to be measured, and allowed probabilistic models to be constructed for statistically defensible cell populations (e.g., a gamma function to describe
cell area distributions, black line in c). (Scale bars= 100 μm.) The underlying data are provided in the BioStudies database under the accession code
S-BSST249 and in Supplementary Data 1
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Fig. 9). The ab initio prediction of a negative binomial
distribution is worthy of note as this probability function was
found to be the best curve-ﬁt model of the measured NLV
distribution reported in previous work11. The predicted total
nanoparticle ﬂuorescence per cell (Eq. 13) using these distribu-
tions is also in excellent agreement with the experiment (Fig. 3c
and Supplementary Fig. 9) (N.B., Supplementary Note 2 contains
a full breakdown of all model parameters and instructions for
ﬁtting. Supplementary Data 2 additionally contains an Excel
version of the model, which can be used to apply the model using
results obtained from any image analysis routine, and without
dedicated programming experience).
The role of cell cycle position on nanoparticle uptake. This
prediction can be used to explore the effect of cell state on the
uptake of nanoparticles, and we demonstrate this capability by
clarifying the role of cell cycle on nanoparticle uptake—a subject of
some current controversy18–20. The exposure times in the experi-
ments herein were speciﬁcally chosen to isolate and hence allow
investigation of the mechanisms of particle uptake. The short
duration exposure ensures that the effect of vesicle fusion is mini-
mised21 and that the depletion of available nanoparticles from the
exposure solution is limited enough not to impact the results22. The
short experiment timeframe also ensures that the uptake occurs in a
limited window within a much longer cell cycle (~1 cf. 24 h) and so,
cells may be viewed as being in a quasi-stationary state during the
exposure, i.e., there is minimal progression through cell cycle during
the particle uptake period. The cell cycle positions of individuals
within the populations used in the experiment are asynchronous
and therefore we would expect the population sample to contain
cells from all points across the cell cycle. However, we note that the
same parameter value for λ, the endosome formation rate, is used
for each cell type irrespective of the dosing conditions. This implies
that the rate of uptake is independent of cell cycle. To further
investigate this, we gated on regions of the nuclear ﬂuorescence
distribution to select G1 and G2 cells based on the DNA content of
their nuclei (Fig. 4a). The cells in G2 clearly show increased
numbers of NLVs compared with those in G1 (Fig. 4b); however,
given the nature of the cell cycle, the cells in G2 are also larger than
those in G1. Our model includes the area of the cell in the endo-
some generation distribution and therefore a more appropriate
comparison is the NLV per unit area (Fig. 4c). When corrected for
cell area, the dose distributions for G1 and G2 cells are identical
(null hypothesis accepted p value= 0.586 and two-distribution
Kolmogorov–Smirnov stat= 0.028 at a 0.1% signiﬁcance level).
These results help clarify a debate presented in recent correspon-
dence about the role of cell cycle in controlling nanoparticle
dose18,20 as the ambiguity introduced by confounding factors of
different cell area and time integration of dose are removed in this
study. Crucially λ, the instantaneous formation rate of nanoparticle-
loaded endosomes, in terms of concentration per unit area is
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Fig. 2 NLV analysis across different cell lines and exposure conditions. a, b Typical ﬁelds-of-view for the BEAS-2B cells demonstrating the expected
increase in the number of NLVs per cell that occurs when the nanoparticle exposure dose–time product (DTP) was increased from 2 nM h (a) to 5 nM h
(b). c, d Taken across all image data, the mean number of NLVs per cell (blue circles) and the mean intensity of each NLV (orange crosses) are plotted
versus the dose–time product for the BEAS-2B and A549 cells. The blue and orange lines represent least squares ﬁrst-order polynomial ﬁts to the mean
number of NLVs per cell or NLV intensity versus the dose–time product (respectively). The plots show that whilst the mean number of NLVs per cell
(blue dashed line) increases with increasing exposure, the NLV intensity (i.e., proportional to the number of nanoparticles per vesicle) (orange line)
remains remarkably similar. e, f This stability in the nanoparticle dose per endosome is visually apparent when 100 NLVs are randomly chosen from
the two exposures shown in a/b: the montaged panels of NLV look near identical despite a 2.5-fold increase in the dose–time product. g Four typical
NLV intensity histograms chosen from both cell lines and across the full 16-fold range of the dose–time product. The black line is the same, simultaneous
ﬁt to all of the histograms, demonstrating the insensitivity of the nanoparticle dose per vesicle to the initial administered dose or exposure duration.
(Scale bars= 100 μm.) The underlying data are provided in the BioStudies database under the accession code S-BSST249
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constant; therefore, the internal biological processes of the cell cycle
do not impact endosome formation at the membrane.
Discussion
In summary, we present an analytical, probabilistic model
of nanoparticle dose, based on a mechanistic framework
that considers the arrival of particles at the cell membrane
and the availability of a forming endosome to take receipt
of this delivery. In this way, the data suggests forming endo-
somes sample nanoparticles/agglomerates as they arrive at
the cell surface on the basis of availability. Here, the model
was shown to accurately predict the nanoparticle dose deliv-
ered to cells across a population over a range of exposure
conditions, thus providing the ability to model pharmacoki-
netics. At the current time, however, the model presented was
developed and tested on the basis of short exposure durations
(0.5–2.0 h) rather than on the more lengthy time-integrated
exposures that are typical in the ﬁeld. Whilst this was extre-
mely helpful in showing that cell area, which is correlated with
the cell cycle position, is the driver of any perceived cell-cycle
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Fig. 3 Measurements and theoretical predictions of nanoparticle cellular delivery. a Schematic of nanoparticle uptake by endocytosis. Nanoparticle uptake
is dependent on nanoparticles and/or agglomerates arriving at the site of a forming endosome. Given the timescales of particle arrival in the context of cell
membrane turnover by endocytosis, it is highly improbable that a forming endosome will encounter more than one arrival event under physiologically
relevant dosing conditions. In turn, the formation of more unloaded than nanoparticle-loaded vesicles (NLVs) can be expected. b Histograms showing the
number of NLVs formed per cell across the cell population for both BEAS-2B and A549 cells under different exposure conditions (DTP= dose–time
product). The black curves are the predicted NLV distributions (see Methods, Eq. 12) using the value of λ= 0.00107 nM−1 h−1 m−2 for BEAS-2B cells and
λ= 0.00135 nM−1 h−1 m−2 for A549 cells. We note that the ﬁt to the 8.0 nM h data for the A549 cells is not as convincing as for the other experiments.
However, the mean NLV count was lower than expected for this dose/exposure combination (see Fig. 2d), indicative of a slight error in dosing or exposure
duration. If this is corrected for by using an expected value of 7.2 nM h provided by the straight line ﬁt to the data (indicated by arrow, Fig. 2d), the
distribution shown by the dotted black line is obtained. c Histograms of total nanoparticle ﬂuorescence per cell across the cell population for the same
exposure conditions as in b. The black curves are predicted cell intensity distributions (see Methods, Eq. 13). The underlying data are provided in the
BioStudies database under the accession code S-BSST249
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dependence of nanoparticle uptake18,20, future development
should consider further adaption to account for the dilution of
the nanoparticle dose that occurs through endosome inheri-
tance upon cell division and daughter–cell formation13. A
further consideration for effective use of the model for
nanosafety applications is the effect that cell shrinkage due to
toxicity15 will play over longer exposure times.
The results presented here show that for nanoparticles, the
speciﬁc route to cellular internalisation, driven by endosome
formation, produces a dose proﬁle that must be understood
within a dual context of dose per vesicle and dose per cell. It is
important to note, therefore, that the ability of the model to
encompass this duality suggests its relevance to other modes
of uptake, e.g., viral/vector delivery efﬁciency, microparticle
and exosome uptake, etc. In contrast to molecular agents, the
fundamental event underpinning particle dosing is the for-
mation of the drug carrier (endosome)—not the contact of the
drug with the cell. This, together with the rarity of event
occurrence when using nanomolar concentrations typical of
in vitro nanoparticle assays, results in a binary outcome of
ﬁxed dose per vesicle and a linear dependence of dose per cell
upon exposure parameters. The importance of these ﬁndings
to nanoparticle pharmacology is therefore context dependent.
If total particle dose per cell is the required measure, then this
is well behaved and suitably captured within the typical dose-
response assay. However, the pharmacology of nanoparticles
is often determined by the vesicular load rather than total cell
dose, with particle release strategies based on charge buildup
(proton sponge)23 or other particle-driven chemical reac-
tions24–26, which ultimately action through disruption of the
vesicular membrane. Here, the number of particles per
endosome is the important factor and our results indicate
limited ability to control this at the dose concentrations
typically used within nanomedicine and nanotoxicology
studies.
Methods
Cell culture and nanoparticle exposures. Normal bronchial (BEAS-2B) and lung
carcinoma (A549) cells lines were purchased from ATCC® (product numbers
#CRL-9609 and #CLL-185, respectively). Cultures were maintained under standard
conditions (37 °C, 5% CO2, 95% humidity) in glutamine-containing Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM; #D5796, Sigma-Aldrich, UK), supplemented
with 10% foetal bovine serum (FBS; #10438018, Thermo-Fisher, UK) and 1%
penicillin–streptomycin (#15240062, Thermo-Fisher). Prior to the initiation of
experiments, cells were maintained at ≤75% conﬂuency for at least 72 h by routine
sub-culturing involving trypsinisation (#25300054, Thermo-Fisher), centrifugation
(185 × g, 5 min) and re-seeding in T75 culture ﬂasks (#658175, Greiner Bio-One,
UK). For imaging experiments, cells were seeded at 9000 cells cm−2 in 4-well-
chambered coverglass slides (#155383, Thermo-Fisher, UK) and returned to the
incubator to adhere and acclimatise for 12 h. The cells were then pulse-loaded with
commercially available Qtracker 705 quantum dot (705 nm emission, CdTe–ZnS
core-shell composition) nanoparticles (#Q25061MP, Thermo-Fisher) for 0.5–2 h at
concentrations of 0.5–5 nM. Non-internalised nanoparticles were then thoroughly
washed out using three changes of Hank’s buffered salt solution (HBSS; #14170112,
Thermo-Fisher). The cells were then ﬁxed (5 min, 4% paraformaldehyde) and
cytoplasmic RNA was digested using 100 μg mL−1 ribonuclease (#R4875, Sigma).
Stains. Cell membranes and nuclei were ﬂuorescently counterstained by 10 min
incubation in HBSS containing 5 μg mL−1 wheat germ agglutinin-AlexaFluor 555
conjugate and 1 μg mL−1 Hoechst 33342 (#W32464 and #62249, respectively,
Thermo-Fisher). Counterstained cells were then washed with three changes of
HBSS prior to mounting in 1 M Tris-buffered glycerol containing 25 mgmL−1
diazabicyclo[2,2,2]octane (D27802, Sigma) as an antifade reagent.
Image acquisition. Images were collected using a LSM-710 laser scanning confocal
microscope equipped with a 20×/0.75 objective (Carl-Zeiss, UK). Care was taken
to use an optical section that exceeded the depth of the cells to ensure all NLV
events were captured. Use of an automated stage and multi-position mode allowed
>100 images to be collected semi-automatically for each dose–time exposure
combination from across the culture well, and typically yielded ~104 cells or ~105
NLVs per experiment. Images were collected in 16-bit at 2048 × 2048 pixel
resolution yielding a ﬁeld-of-view coverage of ~710 μm2 per image.
Image analysis. Images were visually inspected to remove out-of-focus or
debris/artefact-containing ﬁelds. The freely available CellProﬁler software12 was
then used to segment each cell’s nucleus, membrane-delineated cell outline and
all constituent NLVs. We include the complete image analysis pipeline used in
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Fig. 4 The role of cell cycle position on nanoparticle uptake. a A typical per-cell nuclear intensity (Hoechst 33342) histogram showing gating of cells within
the characteristic G1 or G2 cell cycle positions. b Histograms showing the distributions of the number of NLVs per cell for the cell populations selected by
the G1 or G2 cell cycle gates shown in a. An increase in the average number of NLVs per cell is apparent for the G2 cell population, and a two-sample
Kolmogorov–Smirnov (KS) test rejects the null hypothesis at the 5% signiﬁcance level that the two distributions are the same (p= 7.447 × 10−35, two-
sample Kolmogorov–Smirnov stat= 0.229). c Replotted histograms of the data shown in b, with the number of NLVs per cell normalised against each cell’s
area. The two distributions now appear identical, and the null hypothesis that the two distributions are the same is not rejected even at the 0.1%
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CellProﬁler to segment the cells and measure the shape and integrated intensity of
the ﬂuorescent stains in each resulting object alongside sample images from the
microscope in Supplementary Note 1 and Supplementary Data 1. We also include
typical images of the segmentation for all dose–time exposure combinations to
demonstrate the robustness of the in situ measurement approach (Supplementary
Figs. 1–4). In brief, cell nuclei and NLVs were directly segmented as ‘primary
objects’ using the Hoechst 33342 and Qtracker 705 signals, respectively. The cell
bodies themselves were identiﬁed as ‘secondary objects’ using a modiﬁed watershed
approach; using the nuclei as seeds for each cell-object before propagation to ﬁnd
the cell boundaries in the WGA-555 cell membrane channel. Care was taken to
isolate the true NLV signal against background by thresholding the channel against
an image stack treated/imaged identically but unexposed to Qtracker 705 (shown,
Supplementary Figs. 3, 4). Before commencing data analysis, cells partially
obscured at the edges of the imaging frame and that fell outside the 5th and 95th
percentiles of cell area were discarded to remove incorrectly segmented cell
objects27.
Estimation of numbers of unloaded vesicles (ULVs) per cell. As above, cells
were seeded at 9000 cells cm−2 in 4-well chambered coverglass slides and returned
to the incubator to acclimatise for 12 h. The cells were then washed with one
change prewarmed HBSS before addition of a 7.5-μg- mL−1 solution of WGA-
Alexa Fluor 555 conjugate for 10 min to label cell membranes. Excess stain was
then washed out with HBSS, before addition of complete phenol-red-free DMEM
and return of the cells to the microscope’s live cell incubator for 1 h under standard
conditions. Internalisation of the WGA-555 labelled membrane into endosomes
over the 1 h period was then measured by quantifying the formation of bright detail
foci in each cell (process described in full, Supplementary Fig. 8). Images were
collected at 2048 × 2048 pixel resolution using 20×/0.75 objective yielding a ﬁeld-
of-view coverage of ~425 μm2 per image.
A statistical probability distribution model. Endosomes are formed by an active
area of the membrane (often decorated with endosome promoting complexes such
as clathrin), which invaginates the outer membrane forming an internalised vesicle
or endosome9. The activation of the endocytic process on the cell membrane can be
described as a spatial Poisson process, and therefore the probability distribution of
the number of endosomes, Nend generated by a cell of area A within a given time, t,
is given by,
P Nendð Þ ¼
μAtð ÞNend eμAt
Nend!
; ð2Þ
where μ is the endosome generation rate per unit area per unit time. The prob-
ability of a cell generating an NLV, P(NNLV) relates to the conditional sequence
of an endosome formation event, P(Nend) and the arrival of a nanoparticle/
agglomerate at the speciﬁc cell membrane location during the endosome formation
period, P(Narr).
i.e.,
P NNLVð Þ ¼ P Nendð Þ ´P Narrð Þ: ð3Þ
If we assume that all endosomes have the same area and turnover rate (remain
at the surface for the same duration), then we can also assume that the capture of a
nanoparticle cluster by an endosome is a Poisson process:
P Narrð Þ ¼
ΔNarr eΔ
Narr!
; ð4Þ
where Δ describes the rate of arrival of particles/agglomerates in the forming
endosome. The assumption that endosomes have similar areas during formation
appears to be valid15 when the arriving particle aggregates are small, but this
approximation may break down at high doses where large agglomerates form; or,
where the dose is sufﬁcient that more than one particle arrives during endosome
formation4.
Probability of particle capture. The probability of at least one nanoparticle cluster
arriving (i.e., an NLV being formed) is given by:
P Narr  1ð Þ ¼ 1 P Narr ¼ 0ð Þ; ð5Þ
i:e: P Narr  1ð Þ ¼ 1 eΔ: ð6Þ
P Narr  1ð Þ ¼ 1 1 Δþ
Δ2
2
 Δ
3
6
þ ¼
 
; ð7Þ
∴ P Narr  1ð Þ  Δ: ð8Þ
In this derivation, we have assumed that Δ is small so that higher order
nonlinear terms do not contribute in the exponential expansion. This
approximation has been proven to be valid for the physiologically relevant doses
in previous work21, where nanoparticle count per endosome was experimentally
determined using TEM and predicted using a particle transport model developed
by Hinderliter et al.28. This demonstrated that the arrival rate of the particles was
slow enough (10–100 times slower than the endosome formation rate) that the
Poisson arrival probability distribution P(Narr) is dominated by Narr = 0. Therefore,
the greatest probability is that no particles arrive at the site of an endosome during
its formation and events where there are more than one particle (Narr > 1) are rare.
Furthermore, if we assume that the probability of arrival of at least one particle
or agglomerate in the forming endosome is proportional to the concentration of
the nanoparticle dose, C, then
P Narr  1ð Þ ¼ κC; ð9Þ
where κ is a proportionality constant. Therefore, combining equations, we obtain
P NNLVð Þ ¼
μAtð ÞNend eμAt
Nend!
´ κC; ð10Þ
which is simply Poisson thinning18 with a probability of κC; simplifying we obtain,
P NNLVð Þ ¼
λACtð ÞNNLV eλACt
NNLV!
; ð11Þ
where λ= μκ is the rate of uptake of at least one particle/agglomerate via
endocytosis per unit concentration per unit area. We note that the analysis has
assumed that the arrival of the nanoparticles at the surface has not initiated the
endosome formation, which is believed realistic for the Qtracker nanoparticles we
have used29,30. If, however, this was the case, the model would still be valid—just
with κC tending towards 1—as, nearly every arriving particle would be expected
to form an NLV.
The measurement of many cells allows us to measure the distribution of area for
a cell population (Fig. 1c) and the most appropriate mathematical form to describe
these data is a gamma distribution (Supplementary Figs. 6, 7), described by a shape
factor α and scale factor β.
Assuming the endocytic rate per unit area, λ to be constant for all cells in the
population, then the term (λACt) is deﬁned by the area gamma function. A Poisson
process with a rate deﬁned by a gamma function is a negative binomial31.
Therefore, the probability of NLVs is given by:
p NNLV; r; pð Þ ¼
Γ r þ NNLVð Þ
NNLV!Γ rð Þ
pN 1 pð Þr ; ð12Þ
where now r= α and p= βλCt /(1+βλCt).
To calculate the total nanoparticle ﬂuorescence per cell, we simply convolve the
NLV per cell distribution with the intensity of the NLV (INLV) distribution.
Icell NNLVð Þ ¼
XNNLV
0
NNLV
Z1
0
p INLVð ÞINLVdINLV: ð13Þ
The integral in Eq. 13 can be performed stochastically by sampling from the
experimental histograms, or numerically by integrating the theoretical ﬁt (Fig. 2g).
We note that the assumption that the endosome formation rate is much faster than
the particle arrival rate allows the derivation of the simple analytic expression for
the NLV distribution. However, even if this assumption breaks down for very
high dose/duration exposures, or due to vesicular fusion at longer exposure
periods, a simple numerical model can be used by applying the same principles.
Likewise, for longer exposure times, cell division, where the NLVs are inherited by
the daughter cells (effectively diluting the number of NLVs per cell) must be
considered in any predictive model32. Clearly this invalidates the simple analytic
expression for NLV uptake and a more complicated numerical model is required.
Mean dose per cell. The experimentally determined dose per cell is seen to be a
product of concentration and the duration of exposure, i.e., ν / C ´ t. To relate this
to the statistical model presented above, we require the mean of the negative
binomial PDF, νnb:
νnb ¼
pr
1 p : ð14Þ
Substituting for p and r, using the expressions given above, results in the
expression:
νnb ¼ λ ´ αβ ´Ct: ð15Þ
The α, β and λ terms are constant, so Eq. 15 shows that the probabilistic model
for NLV number also scales linearly with the time/dose product. (N.B.,
Supplementary Note 2 contains a full breakdown of all model parameters and
instructions for ﬁtting. Supplementary Data 2 additionally contains an Excel
version of the model, which can be used to apply the model using results obtained
from any image analysis routine, and without dedicated programming experience).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Example raw microscopy ﬁles and the complete CellProﬁler image analysis pipeline are
provided in Supplementary Data 1. All raw confocal data, as well as the image analysis
measurement ﬁles used to produce the results and derive the model, alongside all code to
produce each component of the Figures are provided in the BioStudies database under
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the accession code S-BSST249. Supplementary Note 2 additionally provides a complete
list of all model parameters alongside dedicated model ﬁtting instructions.
Supplementary Data 2 further provides an Excel version of the nanoparticle uptake
model, which can be used with results obtained from any image analysis routine, and
without dedicated programming experience. A reporting summary for this article is
available as a Supplementary Information ﬁle. All other data supporting the ﬁndings of
this study are available from the corresponding authors on reasonable request.
Code availability
All computer code necessary to reproduce the Figures is provided in the BioStudies
database under the accession code S-BSST249.
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